TuHURA has an exclusive right to negotiate to acquire Kineta’s KVA12123 Immuno-Oncology Drug Program Kineta will receive a $5 million…
PRESS RELEASE Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discovery Synsight provides…
Compte tenu de la dynamique très positive de nos ventes observée sur le premier semestre (croissance du chiffre d’affaires attendue…
Sébastien Huron leaves the company, Habib Ramdani takes over while the Group recruits its next chief executive officer Virbac announces…
£90m ($114m) series A co-led by new leading life science investors Novo Holdings and AbingworthAdditional new investors British Patient Capital,…
Press release Ecully, July 8, 2024 – 8 a.m. Spineway continues its sales and marketing efforts in Europe The Spineway Group,…
PRESS RELEASE Memo Therapeutics AG appoints Paul Carter as Chairperson Virology and commercial expertise will support Phase III readiness and…
PRESS RELEASE AB SCIENCE REPORTS POSTIVE RESULTS OF ITS PHASE 2 STUDY EVALUATING MASITINIB IN COVID-19 Paris, 8 July 2024,…
DUBAI, United Arab Emirates, July 07, 2024 (GLOBE NEWSWIRE) -- At DP World's Aviv Clinics Dubai, the world’s most advanced…
Toronto, Ontario and Los Angeles, California--(Newsfile Corp. - July 8, 2024) - The Tinley Beverage Company Inc. (CSE: TNY) (OTCQB: TNYBF)…